Biowell Laboratories
Medicap Ginkgo Biloba
LNHPD
23457681
Formula hash
cae217e5bb9d
Catalog
318
products
With avoid flag
0
products
FDA recalls
0
history
CAERS
0
reports
Clean labelObjective label signals
Flagged excipients
0
none
FDA recalls
0
no recall history
CAERS reports
0
FDA consumer events
Certifications
0
none recorded
No authority-flagged excipients or recalls. · Every flag below links to the authority's published citation.
NIH LiverTox
1 ingredient with hepatotoxicity classification
Worst severity: Category D
- GinkgoCategory D
LiverTox Category D (hepatotoxicity — separate concern from IARC Group 2B carcinogenicity classification). A handful of hepatitis reports.
LiverTox →
Supplement Facts
5 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| Bacopa monnieri BacopaherbUNII · DUB5K84ELI | 100.0 mg | — |
| 2,5-Cyclohexadiene-1,4-dione, 2-[(2E ,6E ,10E ,14E ,18E ,22E ,26E , 30E ,34E )-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl other | 100.0 mg | — |
| 2,5-Cyclohexadiene-1,4-dione, 2-[(2E ,6E ,10E ,14E ,18E ,22E ,26E , 30E ,34E )-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl other | 100.0 mg | — |
| Ginkgo biloba GinkgoherbUNII · 19FUJ2C58T LiverTox D | 120.0 mg | — |
| Ginkgo biloba GinkgoherbUNII · 19FUJ2C58T LiverTox D | — | — |